secwatch / observer
8-K filed June 5, 2023, 7:59 PM ET ticker VNRX CIK 0000093314
other material confidence high sentiment negative materiality 0.75

VolitionRx prices $16.5M public offering of 13M shares at $1.27 per share

VOLITIONRX LTD

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

VOLITIONRX LTD entered into Underwriting Agreement with Prime Executions, Inc., doing business as Freedom Capital Markets valued at approximately $15.4 million (effective 2023-06-01).

Action
entry
Agreement
underwriting
Counterparty
Prime Executions, Inc., doing business as Freedom Capital Markets
Value
approximately $15.4 million
Effective
2023-06-01
Exact text from the filing
On June 1, 2023, VolitionRx Limited (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Prime Executions, Inc., doing business as Freedom Capital Markets (“Freedom”), as representative of the underwriters named therein (collectively, the “Underwriters”), pursuant to which the Company agreed to issue and sell an aggregate of 13,000,000 shares (the “Firm Shares”) of its common stock, par value $0.001 per share (the “Common Stock”), to the Underwriters.
View on SEC.gov

281 material agreements filed in the last 30 days. Browse all material agreements →

VOLITIONRX LTD filing history →

Source: SEC EDGAR
accession 0001477932-23-004228
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.